494 related articles for article (PubMed ID: 29544351)
1. Current and future therapeutic approaches for the treatment of small cell lung cancer.
Rossi A; Tay R; Chiramel J; Prelaj A; Califano R
Expert Rev Anticancer Ther; 2018 May; 18(5):473-486. PubMed ID: 29544351
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for small-cell lung cancer: emerging evidence.
Reck M; Heigener D; Reinmuth N
Future Oncol; 2016 Apr; 12(7):931-43. PubMed ID: 26882955
[TBL] [Abstract][Full Text] [Related]
3. The evolving landscape of immunotherapy in small-cell lung cancer: A focus on predictive biomarkers.
Gelsomino F; Lamberti G; Parisi C; Casolari L; Melotti B; Sperandi F; Ardizzoni A
Cancer Treat Rev; 2019 Sep; 79():101887. PubMed ID: 31491661
[TBL] [Abstract][Full Text] [Related]
4. Second-line treatments of small-cell lung cancers.
Baize N; Monnet I; Greillier L; Quere G; Kerjouan M; Janicot H; Vergnenegre A; Auliac JB; Chouaid C
Expert Rev Anticancer Ther; 2017 Nov; 17(11):1033-1043. PubMed ID: 28849951
[TBL] [Abstract][Full Text] [Related]
5. Novel targeted strategies to overcome resistance in small-cell lung cancer: focus on PARP inhibitors and rovalpituzumab tesirine.
Van Den Borg R; Leonetti A; Tiseo M; Giovannetti E; Peters GJ
Expert Rev Anticancer Ther; 2019 Jun; 19(6):461-471. PubMed ID: 31148500
[No Abstract] [Full Text] [Related]
6. The role of immunotherapy in small cell lung cancer.
Calles A; Aguado G; Sandoval C; Álvarez R
Clin Transl Oncol; 2019 Aug; 21(8):961-976. PubMed ID: 30637710
[TBL] [Abstract][Full Text] [Related]
7. Optimal drugs for second-line treatment of patients with small-cell lung cancer.
Rossi A; Sacco PC; Sgambato A; Casaluce F; Santabarbara G; Palazzolo G; Maione P; Gridelli C
Expert Opin Pharmacother; 2016; 17(7):969-76. PubMed ID: 26878692
[TBL] [Abstract][Full Text] [Related]
8. Prospects of targeted and immune therapies in SCLC.
Hendriks LEL; Menis J; Reck M
Expert Rev Anticancer Ther; 2019 Feb; 19(2):151-167. PubMed ID: 30590971
[No Abstract] [Full Text] [Related]
9. PD-1 checkpoint blockade alone or combined PD-1 and CTLA-4 blockade as immunotherapy for lung cancer?
Tanvetyanon T; Gray JE; Antonia SJ
Expert Opin Biol Ther; 2017 Mar; 17(3):305-312. PubMed ID: 28064556
[TBL] [Abstract][Full Text] [Related]
10. Progress and challenges in the treatment of small cell lung cancer.
Tartarone A; Giordano P; Lerose R; Rodriquenz MG; Conca R; Aieta M
Med Oncol; 2017 Jun; 34(6):110. PubMed ID: 28456992
[TBL] [Abstract][Full Text] [Related]
11. Rationale for chemotherapy, immunotherapy, and checkpoint blockade in SCLC: beyond traditional treatment approaches.
Spigel DR; Socinski MA
J Thorac Oncol; 2013 May; 8(5):587-98. PubMed ID: 23546044
[TBL] [Abstract][Full Text] [Related]
12. Treatment advances in small cell lung cancer (SCLC).
Waqar SN; Morgensztern D
Pharmacol Ther; 2017 Dec; 180():16-23. PubMed ID: 28579387
[TBL] [Abstract][Full Text] [Related]
13. Opportunities and obstacles of targeted therapy and immunotherapy in small cell lung cancer.
Yu L; Lai Q; Gou L; Feng J; Yang J
J Drug Target; 2021 Jan; 29(1):1-11. PubMed ID: 32700566
[TBL] [Abstract][Full Text] [Related]
14. Role of Immune Checkpoint Inhibitors in Small Cell Lung Cancer.
Cooper MR; Alrajhi AM; Durand CR
Am J Ther; 2018; 25(3):e349-e356. PubMed ID: 29722737
[TBL] [Abstract][Full Text] [Related]
15. Emerging drugs for small cell lung cancer: a focused review on immune checkpoint inhibitors.
Reddy HG; Qin A; Kalemkerian GP
Expert Opin Emerg Drugs; 2020 Sep; 25(3):353-366. PubMed ID: 32683991
[TBL] [Abstract][Full Text] [Related]
16. SCLC-State of the Art and What Does the Future Have in Store?
Kahnert K; Kauffmann-Guerrero D; Huber RM
Clin Lung Cancer; 2016 Sep; 17(5):325-333. PubMed ID: 27397481
[TBL] [Abstract][Full Text] [Related]
17. A new hope: the immunotherapy in small cell lung cancer.
Li Q; Yuan D; Ma C; Liu Y; Ma L; Lv T; Song Y
Neoplasma; 2016; 63(3):342-50. PubMed ID: 26925794
[TBL] [Abstract][Full Text] [Related]
18. The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer.
Horn L; Reck M; Spigel DR
Oncologist; 2016 Aug; 21(8):910-21. PubMed ID: 27354668
[TBL] [Abstract][Full Text] [Related]
19. Development of targeted therapy and immunotherapy for treatment of small cell lung cancer.
Saito M; Shiraishi K; Goto A; Suzuki H; Kohno T; Kono K
Jpn J Clin Oncol; 2018 Jul; 48(7):603-608. PubMed ID: 29762727
[TBL] [Abstract][Full Text] [Related]
20. Treatment of extensive-stage small cell lung carcinoma: current status and future prospects.
Demedts IK; Vermaelen KY; van Meerbeeck JP
Eur Respir J; 2010 Jan; 35(1):202-15. PubMed ID: 20044461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]